跳至主要内容
临床试验/CTRI/2023/08/056098
CTRI/2023/08/056098尚未招募3 期

Efficacy of indigenous High Flow Nasal Cannula (HFNC) device in acute hypoxemic respiratory failure when compared to standard HFNC device - NI

Amrita Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. The eligibility criteria for this study would be (1) Inborn babies with respiratory distress (clinical / laboratory)
  • 2. RSS Mild to moderate
  • 3. SPO2 <= 94% on low-flow oxygen therapy or needs a high-flow device
  • 4. In preterm 88-92% ( < 28 weeks)
  • 5. Signs of increased work of breathing on low oxygen

排除标准

  • RSS scoring: Severe respiratory distress
  • Underlying hemodynamic instability
  • Congenital heart disease which is critical
  • midfacial anomalies prohibiting the use of nasal cannula and
  • those requiring immediate intubation and ventilation because of apnea, respiratory failure, or profound hypoxemia
  • Do not Resuscitate (DNR)

研究者

相似试验